chrX-131273860-G-A
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 0P and 7B. BP4_ModerateBS1_SupportingBS2
The NM_001555.5(IGSF1):c.3947C>T(p.Thr1316Ile) variant causes a missense change. The variant allele was found at a frequency of 0.0000282 in 1,206,321 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 12 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001555.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
IGSF1 | NM_001555.5 | c.3947C>T | p.Thr1316Ile | missense_variant | 20/20 | ENST00000361420.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
IGSF1 | ENST00000361420.8 | c.3947C>T | p.Thr1316Ile | missense_variant | 20/20 | 1 | NM_001555.5 | P4 |
Frequencies
GnomAD3 genomes AF: 0.0000448 AC: 5AN: 111505Hom.: 0 Cov.: 23 AF XY: 0.0000594 AC XY: 2AN XY: 33673
GnomAD3 exomes AF: 0.0000164 AC: 3AN: 183202Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 67658
GnomAD4 exome AF: 0.0000265 AC: 29AN: 1094816Hom.: 0 Cov.: 29 AF XY: 0.0000278 AC XY: 10AN XY: 360308
GnomAD4 genome AF: 0.0000448 AC: 5AN: 111505Hom.: 0 Cov.: 23 AF XY: 0.0000594 AC XY: 2AN XY: 33673
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 06, 2022 | The c.3962C>T (p.T1321I) alteration is located in exon 20 (coding exon 19) of the IGSF1 gene. This alteration results from a C to T substitution at nucleotide position 3962, causing the threonine (T) at amino acid position 1321 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at